2393 — Yestar Healthcare Holdings Co Income Statement
0.000.00%
- HK$230.83m
- HK$237.92m
- CNY1.49bn
Annual income statement for Yestar Healthcare Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,931 | 2,805 | 2,913 | 2,410 | 1,490 |
| Cost of Revenue | |||||
| Gross Profit | 849 | 398 | 513 | 399 | 267 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4,710 | 3,016 | 2,707 | 1,450 | 1,531 |
| Operating Profit | 221 | -212 | 206 | 960 | -40.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 59.9 | -485 | 41 | 930 | -51.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 12.7 | -474 | 1.48 | 903 | -69.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 3.33 | -992 | -13.9 | 922 | -75 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.33 | -992 | -13.9 | 922 | -75 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.003 | -0.163 | -0.011 | 0.019 | 0.006 |